文献
J-GLOBAL ID:202202291829144124
整理番号:22A0970519
確定的化学放射線療法を受けた頭頸部癌患者におけるイメージングに基づく低酸素動態の代用マーカーとしてのインターロイキン6:前向きパイロット試験からの結果【JST・京大機械翻訳】
Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation-results from a prospective pilot trial
著者 (20件):
Ruehle Alexander
(Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany)
,
Ruehle Alexander
(German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Wiedenmann Nicole
(Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany)
,
Wiedenmann Nicole
(German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Fennell Jamina T.
(Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany)
,
Fennell Jamina T.
(German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Mix Michael
(Department of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany)
,
Ruf Juri
(Department of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany)
,
Stoian Raluca
(Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany)
,
Stoian Raluca
(German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Thomsen Andreas R.
(Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany)
,
Thomsen Andreas R.
(German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Vaupel Peter
(Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany)
,
Vaupel Peter
(German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Baltas Dimos
(Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany)
,
Baltas Dimos
(German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Grosu Anca-L.
(Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany)
,
Grosu Anca-L.
(German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Nicolay Nils H.
(Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany)
,
Nicolay Nils H.
(German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany)
資料名:
European Journal of Nuclear Medicine and Molecular Imaging
(European Journal of Nuclear Medicine and Molecular Imaging)
巻:
49
号:
5
ページ:
1650-1660
発行年:
2022年
JST資料番号:
A1009A
ISSN:
1619-7070
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)